In the short time since its inception in December 2024, the PGIM India Healthcare Fund has shown promise of being a good opportunity for long-term investment. In this article, we will review the fund in light of the opportunities presented by the Healthcare sector in India.
There are many misconceptions about the healthcare sector, with some believing it is highly concentrated or limited to just pharmaceuticals. In reality, healthcare is a diverse and expansive theme that encompasses various sub-segments, including hospitals, diagnostics, medical devices, discovery, and pharmaceuticals. Each sub-segment in healthcare features distinct business models with unique economic characteristics

Source: PGIM product leaflet. CRO - Contract Research Organization, CDMO - Contract Development and Manufacturing Organization
Healthcare is a complex and under-represented sector within broader indices, necessitating a specialized, active approach. Bottom-up stock picking is of paramount importance in this segment as winners keep rotating between subsegments as shown in the table:

Source- Factset, PGIM India Internal Analysis. For understanding purposes only. The sub-segments are the internal bifurcation of PGIM India AMC. Past performance may or may not be sustained in the future and is not a guarantee of any future returns. Index performance does not signify scheme performance. CDMOs- Contract development and manufacturing organizations, CRO- Contract research organizations.
Under-penetration of health insurance in India results in significantly higher out-of-pocket expenses compared to developed economies. There is huge growth potential for healthcare and allied sectors in India. The drivers of long-term growth of the healthcare industry in the Indian context are:

Source: PHD Research Bureau projections for the years 2030, 2040 and 2047

Source: UN WPP 2024

Source: S&P Household Income Projections; Fitch Solutions Health Expenditure

Source: WHO, Data as of 2021. DM – Developed Market and EM – Emerging Market

Source: IBEF, PHD Research Bureau projections for the years 2030, 2040 and 2047. Disclaimer: The projections have been made to meet the aspirational target of developed economy healthcare levels by 2047

Source: MFI ICRA. Data from 31st August 2004 to 31st April 2025 & 30th April 2007 to 30th April 2025. BSE Healthcare TRI is the benchmark for this fund and Nifty 500 TRI represents the broader market.

Source: Advisorkhoj Research, as on 19th June 2026 * Both benchmark indices are total return indices
The PGIM India Healthcare Fund is an open-ended equity scheme investing in healthcare and pharmaceutical sector, with an objective to seek to generate consistent returns by predominantly investing in equity and equity-related securities of pharmaceutical and healthcare companies. The fund is managed by fund manager A Anandha Padmanabhan, who also manages multiple PGIM India MF schemes and has been tracking the Healthcare domain of Indian equities for over 15 years.
The fund has demonstrated promise since its inception in December 2024. The fund has outperformed its peers (category average) over different investment tenures in the last 1 years (see the chart below).

Source: Advisorkhoj Research as on 19th June 2026
The charts below show that the fund has featured in the top quartile in the two years since its launch. Also, the fund has featured in the top two quartiles in 4 quarters out of the 5 completed quarters since its launch.

Source: Advisorkhoj Research as of 31st March 2026

Source: PGIM India Healthcare Fund product presentation

Source: PGIM India Healthcare Fund product presentation
The current portfolio construction is leaning towards small caps with 46.31% allocation; Large cap allocation is 33.34%, while Midcap stocks are at 18.24%, besides 2.1% of cash for liquidity purposes. The chart below shows the top 5sector allocation as well as the top 5 stocks in the portfolio.

Source: Fund factsheet as of 31st May 2026
The fund is suitable for:
Investors should consult their financial advisers or mutual fund distributors to understand if the PGIM India Healthcare Fund is suitable for them.
Mutual Fund Investments are subject to market risk, read all scheme related documents carefully.
PGIM is the global investment management business of Prudential Financial, Inc. (PFI) USA, with USD 1.5 trillion1 in assets under management. We offer a broad range of investment capabilities through our multi-manager model along with experienced investment teams that assist you in achieving your financial goals. With a glorious legacy of 145 years, PGIM is built on the strength, stability and deep expertise in managing money. We offer you a long-term perspective, having weathered multiple market cycles, and see opportunity in periods of disruption.